研究者業績

中田 孝明

ナカダ タカアキ  (Nakada Taka-aki)

基本情報

所属
千葉大学 大学院医学研究院 教授

J-GLOBAL ID
201801009945149731
researchmap会員ID
B000322449

論文

 425
  • Taka-aki Nakada, Naohisa Masunaga, Shota Nakao, Maiko Narita, Takashi Fuse, Hiroaki Watanabe, Yasuaki Mizushima, Tetsuya Matsuoka
    AMERICAN JOURNAL OF EMERGENCY MEDICINE 34(1) 88-92 2016年1月  査読有り
    Objective: Physiological parameters are crucial for the caring of trauma patients. There is a significant loss of prehospital vital signs data of patients during handover between prehospital and in-hospital teams. Effective strategies for reducing the loss remain a challenging research area. We tested whether the newly developed electronic automated prehospital vital signs chart sharing system would increase the amount of prehospital vital signs data shared with a remote trauma center prior to hospital arrival. Methods: Fifty trauma patients, transferred to a level I trauma center in Japan, were studied. The primary outcome variable was the number of prehospital vital signs shared with the trauma center prior to hospital arrival. Results: The prehospital vital signs chart sharing system significantly increased the number of prehospital vital signs, including blood pressure, heart rate, and oxygen saturation, shared with the in-hospital team at a remote trauma center prior to patient arrival at the hospital (P <.0001). There were significant differences in prehospital vital signs during ambulance transfer between patients who had severe bleeding and non-severe bleeding within 24 hours after injury onset. Conclusions: Vital signs data collected during ambulance transfer via patient monitors could be automatically converted to easily visible patient charts and effectively shared with the remote trauma center prior to hospital arrival. The prehospital vital signs chart sharing system increased the number of precise vital signs shared prior to patient arrival at the hospital, which can potentially contribute to better trauma care without increasing labor and reduce information loss during clinical handover. (C) 2015 Elsevier Inc. All rights reserved.
  • Masashi Taniguchi, Taka-aki Nakada, Koichiro Shinozaki, Yasuaki Mizushima, Tetsuya Matsuoka
    WORLD JOURNAL OF EMERGENCY SURGERY 11 6 2016年1月  査読有り
    Background: Systemic immune response to injury plays a key role in the pathophysiological mechanism of blunt trauma. We tested the hypothesis that increased blood interleukin-6 (IL-6) levels of blunt trauma patients on emergency department (ED) arrival are associated with poor clinical outcomes, and investigated the utility of rapid measurement of the blood IL-6 level. Methods: We enrolled 208 consecutive trauma patients who were transferred from the scene of an accident to a level I trauma centre in Japan and admitted to the intensive care unit (ICU). Blood IL-6 levels on ED arrival were measured by using a rapid measurement assay. The primary outcome variable was prolonged ICU stay (length of ICU stay > 7 days). The secondary outcomes were 28-day mortality, probability of survival and Abbreviated Injury Scale (AIS) scores. Results: Patients with prolonged ICU stay had significantly higher blood IL-6 levels on ED arrival than the patients without prolonged ICU stay (P < 0.0001). The receiver-operating characteristic curves produced an area under the curve of 0.75 (95 % confidence interval [CI], 0.66-0.84; P < 0.0001) for prolonged ICU stay. The patients who had increased blood IL-6 levels on ED arrival had increased 28-day mortality (P = 0.021) and decreased probability of survival (P < 0.0001). The AIS scores for the thorax, abdomen, extremity, and external body regions independently correlated with blood IL-6 levels (unstandardized coefficients [95 % CI] for the thorax: 23.8 [12.6-35.1]; P < 0.0001; abdomen: 42.7 [23.8-61.7]; P < 0.0001; extremity: 19.0 [5.5-32.4]; P = 0.0060; external body regions: 62.9 [13.2-112.7]; P = 0.030); the standardized coefficients for the thorax (0.27) and abdomen (0.28) were larger than those for the extremity (0.18) and external body regions (0.15). Conclusions: Increased blood IL-6 level on ED arrival was significantly associated with prolonged length of ICU stay. Blood IL-6 level on ED arrival independently correlated with the AIS scores for the abdomen and thorax, and, to a lesser extent, those for the extremity and external body regions. The rapid measurement of blood IL-6 level on ED arrival can be utilized as a fast screening tool to improve assessment of injury severity and prediction of clinical outcomes in the initial phase of trauma care.
  • Takashi Fuse, Taka-aki Nakada, Masashi Taniguchi, Yasuaki Mizushima, Tetsuya Matsuoka
    AMERICAN JOURNAL OF EMERGENCY MEDICINE 33(12) 1840.e1-2 2015年12月  査読有り
    Hereditary angioedema (HAE) is a rare genetic disease caused by a deficiency of functional C1 esterase inhibitor that causes swelling attacks in various body tissues. We hereby report a case of out-of-hospital cardiac arrest due to airway obstruction in HAE. Cutaneous swelling and abdominal pain attacks caused by gastrointestinal wall swelling are common symptoms in HAE, whereas laryngeal swelling is rare. Emergency physicians may have few chances to experience cases of life-threatening laryngeal edema resulting in a delay from symptom onset to the diagnosis of HAE. Hereditary angioedema is diagnosed by performing complement blood tests. Because safe and effective treatment options are available for the life-threatening swellings in HAE, the diagnosis potentially reduces the risk of asphyxiation in patients and their blood relatives.
  • Kawaguchi R, Nakada TA, Oshima T, Abe R, Matsumura Y, Oda S
    Acute medicine & surgery 2(4) 244-249 2015年10月  査読有り
  • Nobuya Kitamura, Taka-aki Nakada, Koichiro Shinozaki, Yoshio Tahara, Atsushi Sakurai, Naohiro Yonemoto, Ken Nagao, Arino Yaguchi, Naoto Morimura
    CRITICAL CARE 19 2015年9月  査読有り
    Introduction: Previous studies evaluating whether subsequent conversion to shockable rhythms in patients who had initially non-shockable rhythms was associated with altered clinical outcome reported inconsistent results. Therefore, we hypothesized that subsequent shock delivery by emergency medical service (EMS) providers altered clinical outcomes in patients with initially non-shockable rhythms.Methods: We tested for an association between subsequent shock delivery in EMS resuscitation and clinical outcomes in patients with initially non-shockable rhythms (n = 11,481) through a survey of patients after out-of-hospital cardiac arrest in the Kanto region (SOS-KANTO) 2012 study cohort, Japan. The primary investigated outcome was 1-month survival with favorable neurological functions. The secondary outcome variable was the presence of subsequent shock delivery. We further evaluated the association of interval from initiation of cardiopulmonary resuscitation to shock with clinical outcomes.Results: In the univariate analysis of initially non-shockable rhythms, patients who received subsequent shock delivery had significantly increased frequency of return of spontaneous circulation, 24-hour survival, 1-month survival, and favorable neurological outcomes compared to the subsequent not shocked group (P < 0.0001). In the multivariate logistic regression analysis, subsequent shock was significantly associated with favorable neurological outcomes (vs. not shocked; adjusted P = 0.0020, odds ratio, 2.78; 95 % confidence interval, 1.45-5.30). Younger age, witnessed arrest, initial pulseless electrical activity rhythms, and cardiac etiology were significantly associated with the presence of subsequent shock in patients with initially non-shockable rhythms.Conclusions: In this study of cardiac arrest patients with initially non-shockable rhythms, patients who received early defibrillation by EMS providers had increased 1-month favorable neurological outcomes.
  • Kitamura N, Nakada TA, Shinozaki K, Tahara Y, Sakurai A, Yonemoto N, Nagao K, Yaguchi A, Morimura N, SOS-KANTO, Study Group
    Critical care (London, England) 19(1) 322-322 2015年9月  査読有り
  • 西田 修, 小倉 裕司, 井上 茂亮, 射場 敏明, 今泉 均, 江木 盛時, 垣花 泰之, 久志本 成樹, 小谷 穣治, 貞広 智仁, 志馬 伸朗, 中川 聡, 中田 孝明, 布宮 伸, 林 淑朗, 藤島 清太郎, 升田 好樹, 松嶋 麻子, 松田 直之, 織田 成人, 田中 裕, 日本版重症敗血症診療ガイドライン2016作成特別委員会
    日本救急医学会雑誌 26(8) 312-312 2015年8月  
  • 松嶋 麻子, 西田 修, 小倉 裕司, 井上 茂亮, 射場 敏明, 今泉 均, 江木 盛時, 垣花 泰之, 久志本 成樹, 小谷 穣治, 貞広 智仁, 志馬 伸朗, 中川 聡, 中田 孝明, 布宮 伸, 林 淑朗, 藤島 清太郎, 升田 好樹, 松田 直之, 織田 成人, 田中 裕, 日本版重症敗血症診療ガイドライン2016作成特別委員会
    日本救急医学会雑誌 26(8) 312-312 2015年8月  
  • 井上 茂亮, 畠山 淳司, 齋藤 伸行, 福家 良太, 近藤 豊, 一二三 亨, 武居 哲洋, 西田 修, 小倉 裕司, 射場 敏明, 今泉 均, 江木 盛時, 垣花 泰之, 久志本 成樹, 小谷 穣治, 貞広 智仁, 志馬 伸朗, 中川 聡, 中田 孝明, 布宮 伸, 林 淑朗, 藤島 清太郎, 升田 好樹, 松嶋 麻子, 松田 直之, 織田 成人, 田中 裕, 日本版重症敗血症診療ガイドライン2016作成特別委員会
    日本救急医学会雑誌 26(8) 312-312 2015年8月  
  • 小倉 裕司, 西田 修, 井上 茂亮, 射場 敏明, 今泉 均, 江木 盛時, 垣花 泰之, 久志本 成樹, 小谷 穣治, 貞広 智仁, 志馬 伸朗, 中川 聡, 中田 孝明, 布宮 伸, 林 淑朗, 藤島 清太郎, 升田 好樹, 松嶋 麻子, 松田 直之, 織田 成人, 田中 裕, 日本版重症敗血症診療ガイドライン2016作成特別委員会
    日本救急医学会雑誌 26(8) 313-313 2015年8月  
  • Matsumura Y, Nakada TA, Hayashi Y, Oshima T, Oda S
    Acute medicine & surgery 2(3) 219-222 2015年7月  査読有り
  • Kazuhiro Katsuhara, Taka-aki Nakada, Mami Yamada, Takashi Fuse, Koji Idoguchi, Tetsuya Matsuoka
    JOURNAL OF ARTIFICIAL ORGANS 18(2) 173-176 2015年6月  査読有り
    Liver abscess remains a life-threatening disease, particularly when it results in systemic organ failure necessitating intensive care. Only few cases of respiratory failure caused by liver abscess and treated with veno-venous extracorporeal membrane oxygenation (ECMO) have been reported. Here we present a case of liver abscess with rapid progression of multiple organ dysfunction, including severe acute respiratory failure on admission to the intensive care unit (ICU). Upon admission, we immediately initiated artificial organ support systems, including ventilator, continuous renal replacement therapy, and cardiovascular drug infusion for septic multiple organ failure and source control. Despite this initial management, respiratory failure deteriorated and V-V ECMO was introduced. The case developed abdominal compartment syndrome, for which we performed a bedside decompressive laparotomy in the ICU. The case gradually recovered from multiple organ failure and was discharged from the ICU on day 22 and from the hospital on day 53. Since liver abscess is potentially lethal and respiratory failure on admission is an additional risk factor of mortality, V-V ECMO may serve as an adjunctive choice of artificial organ support for cases of severe acute respiratory failure caused by liver abscess.
  • Taka-aki Nakada, Shota Nakao, Yasuaki Mizushima, Tetsuya Matsuoka
    ACADEMIC EMERGENCY MEDICINE 22(6) 708-713 2015年6月  査読有り
    ObjectivesWhether sex affects the mortality of trauma patients remains unknown. The hypothesis of this study was that sex was associated with altered mortality rates in trauma. MethodsA retrospective review of trauma patients' records in the Japan Trauma Data Bank was conducted (n=80,813) from 185 major emergency hospitals across Japan. The primary outcome variable was in-hospital mortality within 28days. Secondary outcome variables included serious injuries to different body regions with an Abbreviated Injury Scale of 3. ResultsIn the analysis of 80,813 trauma patients, males had significantly greater 28-day mortality compared to females (adjusted p=0.0072, odds ratio [OR]=1.14, 95% confidence interval [CI]=1.06 to 1.23) via logistic regression analysis adjusted for age, mechanism, Injury Severity Score, Revised Trauma Score, and potential preexisting risk factors. Of 10 injury categories examined, sex significantly affected in-hospital 28-day mortality rate in falls (adjusted p&lt;0.0001, OR= 1.34, 95% CI=1.19 to 1.52). Further analysis of three fall subcategories by falling distance revealed that male patients who fell from ground level had significantly higher 28-day mortality (adjusted p&lt;0.0001, OR= 1.75, 95% CI=1.43 to 2.14) and a significantly greater frequency of serious injury to the head, thorax, abdomen, and spine, but a lower frequency of serious injury to the extremities, compared to female patients. ConclusionsCompared to female trauma patients, male trauma patients had greater 28-day mortality. In particular, ground-level falls had a significant sex difference in mortality, with serious injury to different body regions. Sex differences appeared to be important for fatalities from ground-level falls.
  • 井戸口 孝二, 中尾 彰太, 中田 孝明, 成田 麻衣子, 谷口 昌史, 臼井 亮介, 渡部 広明, 小野 秀文, 水島 靖明, 松岡 哲也, 川村 匡, 井手 亨, 松江 一
    日本外傷学会雑誌 29(2) 208-208 2015年5月  
  • 中尾 彰太, 井戸口 孝二, 中田 孝明, 渡部 広明, 水島 靖明, 松岡 哲也
    日本腹部救急医学会雑誌 35(2) 417-417 2015年2月  
  • 勝原 和博, 中田 孝明, 山田 茉美, 布施 貴司, 井戸口 孝二, 渡部 広明, 水島 靖明, 松岡 哲也
    日本集中治療医学会雑誌 22(Suppl.) [DP51-6] 2015年1月  
  • Taka-aki Nakada, James A. Russell, John H. Boyd, Simone A. Thair, Keith R. Walley
    CRITICAL CARE MEDICINE 43(1) 101-108 2015年1月  査読有り
    Objectives: Mortality from septic shock is highly heritable. The identification of causal genetic factors is insufficient. To discover key contributors, we first identified nonsynonymous single-nucleotide polymorphisms in conserved genomic regions that are predicted to have significant effects on protein function. We then test the hypothesis that these nonsynonymous single-nucleotide polymorphisms across the genome alter clinical outcome of septic shock. Design: Genetic-association study plus in vitro experiment using primary cells plus in silico analysis using genomic DNA and protein database. Setting: Twenty-seven ICUs at academic teaching centers in Canada, Australia, and the United States. Patients: Patients with septic shock of European ancestry (n = 520). Interventions: Patients with septic shock were genotyped for 843 nonsynonymous single-nucleotide polymorphisms in conserved regions of the genome and are predicted to have damaging effects from the protein sequence. Measurements and Main Results: The primary outcome variable was 28-day mortality. Secondary outcome variables were organ dysfunction. Productions of adhesion molecules including interleukin-8, growth-regulated oncogene-alpha, monocyte chemoattractant protein-1, and monocyte chemoattractant protein-3 were measured in human umbilical vein endothelial cells after SVEP1 gene silencing by RNA interference. Patients with septic shock having the SVEP1 C allele of nonsynonymous single-nucleotide polymorphism, SVEP1 c.2080A&gt;C (p. Gln581His, rs10817033), had a significant increase in the hazard of death over the 28 days (hazard ratio, 1.72; 95% CI, 1.31-2.26; p = 9.7 x 10-5) and increased organ dysfunction and needed more organ support (p &lt; 0.05). Silencing SVEP1 significantly increased interleukin-8, growth-regulated oncogene-alpha, monocyte chemoattractant protein-1, monocyte chemoattractant protein-3 production in human umbilical vein endothelial cells under lipopolysaccharide stimulation (p &lt; 0.01). Conclusions: C allele of SVEP1 c.2080A&gt;C (p. Gln581His) single-nucleotide polymorphism, a non-synonymous single-nucleotide polymorphism in conserved regions and predicted to have damaging effects on protein structure, was associated with increased 28-day mortality and organ dysfunction of septic shock. SVEP1 appears to regulate molecules of the leukocyte adhesion pathway.
  • Taka-aki Nakada, John H. Boyd, James A. Russell, Rosala Aguirre-Hernandez, Mark D. Wilkinson, Simone A. Thair, Emiri Nakada, Melissa K. McConechy, Christopher D. Fjell, Keith R. Walley
    JOURNAL OF INNATE IMMUNITY 7(5) 545-553 2015年  査読有り
    Background: Genetic variations contribute to septic shock mortality. To discover a novel locus, we performed in vitro genome-wide association studies (GWAS) and further tested the result in a cohort of septic shock patients. Methods: Two in vitro GWAS using a quantitative trait locus analysis of stimulated IL-6 production in lymphoblastoid cells from 60 individuals of European ancestry were performed. VPS13D rs6685273 was genotyped in European ancestry patients (n = 498). The VPS13D gene was silenced in vitro. Results: Two GWAS using lymphoblastoid cells identified the locus of VPS13D rs6685273 that was significant in the same direction in both GWAS. The VPS13D rs6685273 C allele was associated with increased IL-6 production. Patients with septic shock who had the VPS13D rs6685273 CC genotype had an increased 28-day mortality (p = 0.023) and more organ failure (p &lt; 0.05) compared to the CT/TT genotypes. VPS13D in vitro gene silencing in the HeLa cell line increased IL-6 production. Furthermore, the rs6685273 genotype was associated with differential VPS13D splice variant expression. Conclusions: The VPS13D rs6685273 C allele was associated with increased IL-6 production in vitro. The patients with the VPS13D rs6685273 CC genotype had increased 28-day mortality and increased organ failure. VPS13D appears to regulate IL-6 production. (C) 2015 S. Karger AG, Basel
  • Taka-aki Nakada, Koji Idoguchi, Hiroshi Fukuma, Hidefumi Ono, Shota Nakao, Tetsuya Matsuoka
    F1000Research 3 310 2014年12月19日  査読有り
    Subclavian arterial injury is rare and potentially life-threatening, particularly when it leads to arterial occlusion, causing limb ischemia, retrograde thromboembolization and cerebral infarction within hours after injury. Here we report a blunt trauma case with subclavian arterial injury, upper extremity ischemia, and the need for urgent treatment to salvage the limb and prevent cerebral infarction. A 41-year-old man had a left, open, mid-shaft clavicle fracture and left subclavian artery injury accompanied by a weak pulse in the left radial artery, decreased blood pressure of the left arm compared to the right, and left hand numbness. Urgent debridement and irrigation of the open clavicle fracture was followed by angiography for the subclavian artery injury. The left distal subclavian artery had a segmental dissection with a thrombus. Urgent endovascular treatment using a self-expanding nitinol stent successfully restored the blood flow and blood pressure to the left upper extremity. Endovascular treatment is a viable option for cases of subclavian artery injury where there is a risk of extremity ischemia and cerebral infarction.
  • Matsumura Yosuke, Nakada Takaaki, ABE Ryuzo, Oshima Taku, Oda Shigeto
    CRITICAL CARE MEDICINE 42(12) 2014年12月  査読有り
  • Yosuke Matsumura, Taka-aki Nakada, Ryuzo Abe, Taku Oshima, Shigeto Oda
    PLOS ONE 9(12) e114007 2014年12月  査読有り
    Purpose: The final decision for discharge from the intensive care unit (ICU) is uncertain because it is made according to various patient parameters; however, it should be made on an objective evaluation. Previous reports have been inconsistent and unreliable in predicting post-ICU mortality. To identify predictive factors associated with post-ICU mortality, we analyzed physiological and laboratory data at ICU discharge. Methods: Patients admitted to our ICU between September 2012 and August 2013 and staying for critical care. 2 days were included. Sequential Organ Failure Assessment (SOFA) score; systemic inflammatory response syndrome score; white blood cell count; and serum C reactive protein, procalcitonin (PCT), interleukin-6 (IL-6), lactate, albumin, and hemoglobin levels were recorded. The primary end point was 90-day mortality after ICU discharge. Two hundred eighteen patients were enrolled (195 survivors, 23 non-survivors). Results: Non-survivors presented a higher SOFA score and serum PCT, and IL-6 levels, as well as lower serum albumin and hemoglobin levels. Serum PCT, albumin, and SOFA score were associated with 90-day mortality in multiple logistic regression analysis. Hosmer-Lemeshow test showed chi-square value of 6.96, and P value of 0.54. The area under the curve (95% confidence interval) was 0.830 (0.771-0.890) for PCT, 0.688 (0.566-0.810) for albumin, 0.861 (0.796-0.927) for SOFA score, and increased to 0.913 (0.858-0.969) when these were combined. Serum PCT level at 0.57 ng/mL, serum albumin at 2.5 g/dL and SOFA score at 5.5 predict 90-day mortality, and high PCT, low albumin and high SOFA groups had significantly higher mortality. Serum PCT and SOFA score were significantly associated with survival days after ICU discharge in Cox regression analysis. Conclusions: Serum PCT level and SOFA score at ICU discharge predict post-ICU mortality and survival days after ICU discharge. The combination of these two and albumin level might enable accurate prediction.
  • 渡部 広明, 増永 直久, 福間 博, 成田 麻衣子, 布施 貴司, 林 伸洋, 中尾 彰太, 中田 孝明, 比良 英司, 勝原 和博, 水島 靖明, 松岡 哲也
    エンドトキシン血症救命治療研究会誌 18(1) 46-46 2014年10月  
  • Keith R. Walley, Katherine R. Thain, James A. Russell, Muredach P. Reilly, Nuala J. Meyer, Jane F. Ferguson, Jason D. Christie, Taka-aki Nakada, Chris D. Fjell, Simone A. Thair, Mihai S. Cirstea, John H. Boyd
    SCIENCE TRANSLATIONAL MEDICINE 6(258) 258ra143 2014年10月  査読有り
    A decrease in the activity of proprotein convertase subtilisin/kexin type 9 (PCSK9) increases the amount of low-density lipoprotein (LDL) receptors on liver cells and, therefore, LDL clearance. The clearance of lipids from pathogens is related to endogenous lipid clearance; thus, PCSK9 may also regulate removal of pathogen lipids such as lipopolysaccharide (LPS). Compared to controls, Pcsk9 knockout mice displayed decreases in inflammatory cytokine production and in other physiological responses to LPS. In human liver cells, PCSK9 inhibited LPS uptake, a necessary step in systemic clearance and detoxification. Pharmacological inhibition of PCSK9 improved survival and inflammation in murine polymicrobial peritonitis. Human PCSK9 loss-of-function genetic variants were associated with improved survival in septic shock patients and a decrease in inflammatory cytokine response both in septic shock patients and in healthy volunteers after LPS administration. The PCSK9 effect was abrogated in LDL receptor (LDLR) knockout mice and in humans who are homozygous for an LDLR variant that is resistant to PCSK9. Together, our results show that reduced PCSK9 function is associated with increased pathogen lipid clearance via the LDLR, a decreased inflammatory response, and improved septic shock outcome.
  • 谷口 昌志, 中田 孝明, 渡部 広明, 井戸口 孝二, 水島 靖明, 松岡 哲也
    日本救急医学会雑誌 25(8) 504-504 2014年8月  
  • 中田 孝明, 渡部 広明, 中尾 彰太, 布施 貴司, 成田 麻衣子, 水嶋 靖明, 勝原 和博, 比良 英司, 松岡 哲也
    日本救急医学会雑誌 25(8) 506-506 2014年8月  
  • 布施 貴司, 中尾 彰太, 渡部 広明, 中田 孝明, 水島 靖明, 松岡 哲也
    日本救急医学会雑誌 25(8) 506-506 2014年8月  
  • Waka Takahashi, Taka-aki Nakada, Ryuzo Abe, Kumiko Tanaka, Yosuke Matsumura, Shigeto Oda
    JOURNAL OF CRITICAL CARE 29(4) 693.e1-6 2014年8月  査読有り
    Purpose: Interleukin 6 (IL-6) is a proinflammatory cytokine produced during infections. We hypothesized that IL-6 levels in the cerebrospinal fluid (CSF) would be elevated in bacterial meningitis and useful for diagnosing and predicting neurologic outcomes. Materials and methods: For the differentiation of bacterial meningitis, serum and CSF samples were obtained from patients with an altered level of consciousness. Patients were classified into 3 groups: bacterial meningitis, nonbacterial central nervous system disease, and other site sepsis. Results: Of the 70 patients included in this study, there were 13 in the bacterial meningitis group, 21 in the nonbacterial central nervous system disease group, and 36 in the other site sepsis group. The CSF IL-6 level was significantly higher in the bacterial meningitis group than in the other 2 groups (P &lt; .0001). Of the 5 CSF parameters assessed, CSF IL-6 level exhibited the largest area under the receiver operating characteristic curve (0.962), with a cut-off value of 644 pg/mL (sensitivity, 92.3%; specificity, 89.5%). To examine a potential association between a high CSF level and neurologic outcome, CSF IL-6 levels were divided into 4 quartiles, and each level was compared with the frequency of a good neurologic outcome. The frequency of a good neurologic outcome was significantly lower in the highest CSF IL-6 quartile than in the other 3 quartiles (odds ratio, 0.18; 95% confidence interval, 0.05-0.69; P = .013). Conclusions: Measurement of the CSF IL-6 level is useful for diagnosing bacterial meningitis. (C) 2014 Elsevier Inc. All rights reserved.
  • Kumiko Tanaka, Taka-Aki Nakada, Ryuzo Abe, Sakae Itoga, Fumio Nomura, Shigeto Oda
    Critical Care 18(4) 462 2014年7月24日  査読有り
  • 柄沢 智史, 渡邉 栄三, 安部 隆三, 中田 孝明, 大島 拓, 服部 憲幸, 織田 成人
    肝臓 55(7) 435-436 2014年7月  
  • Matsumura Y, Nakada TA, Oda S
    Acute medicine & surgery 1(1) 37-44 2014年1月  査読有り
  • 渡邉 栄三, 瀬戸口 大典, 織田 成人, 安部 隆三, 大島 拓, 服部 憲幸, 仲村 志芳, 菅 なつみ, 児玉 善之, 山地 芳弘, 中田 孝明
    日本救急医学会雑誌 24(8) 567-567 2013年8月  
  • Yosuke Matsumura, Taka-aki Nakada, Yoshiro Kobe, Noriyuki Hattori, Shigeto Oda
    AMERICAN JOURNAL OF EMERGENCY MEDICINE 31(7) 1152.e1-4 2013年7月  査読有り
    The major symptoms of median arcuate ligament syndrome, celiac axis stenosis, or occlusion compressed by the median arcuate ligament include eating-associated abdominal pain and weight loss. Because celiac stenosis increases retrograde collateral blood flow from the superior mesenteric artery to the celiac artery via the pancreaticoduodenal arcade, a pancreaticoduodenal artery aneurysm could occur at a low incidence rate. Rupture of the pancreaticoduodenal artery aneurysm and hemorrhagic shock are rare. In this report, we present 3 cases of patients who had been well with no abdominal symptoms until the day of admission, when they experienced sudden-onset intra-abdominal hemorrhage and shock. These 3 patients were admitted to the emergency department, and contrast-enhanced computed tomography and radiographic selective catheter angiography revealed intra-abdominal hemorrhage, stenosis of the celiac arteries, and dilated pancreaticoduodenal arcade. Case 1 demonstrated severe hemorrhagic shock, whereas case 2 demonstrated moderate shock. We treated ruptured pancreaticoduodenal artery aneurysms with coil embolization. Case 3 demonstrated complete celiac occlusion and moderate hemorrhagic shock, and no aneurysm was detected.
  • 中田 孝明, 篠崎 広一郎, 安部 隆三, 橋田 知明, 野村 寛久, 田原 良雄, 長尾 建, 矢口 有乃, 森村 尚登, <解析班7班>Regional System Group
    日本臨床救急医学会雑誌 16(3) 295-295 2013年6月  
  • 安部 隆三, 渡邉 栄三, 中田 孝明, 幸部 吉郎, 大島 拓, 服部 憲幸, 鈴木 崇根, 織田 成人
    日本外傷学会雑誌 27(2) 221-221 2013年4月  
  • 川口 留以, 中田 孝明, 大島 拓, 安部 隆三, 渡邉 栄三, 幸部 吉郎, 服部 憲幸, 柄沢 智史, 田中 久美子, 織田 成人
    日本集中治療医学会雑誌 20(Suppl.) 301-301 2013年1月  
  • 田中 久美子, 中田 孝明, 高橋 和香, 安部 隆三, 大島 拓, 幸部 吉郎, 高井 信幸, 川口 留以, 平澤 博之, 織田 成人
    日本集中治療医学会雑誌 20(Suppl.) 411-411 2013年1月  
  • Reiko Oku, Shigeto Oda, Taka-Aki Nakada, Tomohito Sadahiro, Masataka Nakamura, Yoh Hirayama, Ryuzo Abe, Yoshihisa Tateishi, Michihiro Ito, Toru Iseki, Hiroyuki Hirasawa
    Cytokine 61(1) 112-117 2013年1月  査読有り
    Objective: Triggering receptor expressed on myeloid cells-1 (TREM-1) was reported to play a key roll in amplification of production of inflammatory cytokines. TREM-1 is suggested to be a specific biomarker for sepsis for this reason, but the clinical significance of TREM-1 has not been elucidated. We investigated TREM-1 expression on the cell-surface, and plasma levels of soluble TREM-1 (sTREM-1) in patients with non-infectious systemic inflammatory response syndrome (SIRS) and sepsis admitted to the ICU. Methods: Thirty-five patients with SIRS and 21 patients with sepsis admitted to ICU were subjected to the study. TREM-1 expressions on the surfaces of monocytes and neutrophils were measured by flow cytometry. Plasma sTREM-1 level and serum interleukin (IL)-6 level were measured. Results: Septic patients had decreased TREM-1 expression, clearly on neutrophils or to a lesser extent on monocyte compared to SIRS patients on ICU admission (neutrophils p&lt . 0.001, monocyte p&lt . 0.05). TREM-1 expression on neutrophils had a significant inverse correlation with serum IL-6 level (r= -0.64, p&lt . 0.0001). Plasma sTREM-1 level in septic patients was significantly higher than that in SIRS patients (p&lt . 0.05). Plasma sTREM-1 level positively correlated with severity score and non-survivors had increased plasma sTREM-1 level compared to survivors in all SIRS/sepsis patients (p&lt . 0.05). Conclusions: Patients with sepsis had increased soluble TREM-1 and decreased TREM-1 expression on neutrophil compared to SIRS patients. sTREM-1 may be useful to evaluate disease severity and outcome of patients with SIRS or sepsis. © 2012 Elsevier Ltd.
  • Hattori N, Oda N, Watanabe E, Abe R, Nakada T, Sachibe Y, Oshima T, Takahashi W, Matsumura Y, Kimura T
    Chudoku kenkyu : Chudoku Kenkyukai jun kikanshi = The Japanese journal of toxicology 25(4) 312-315 2012年12月  査読有り
  • Petch Wacharasint, Taka-aki Nakada, John H. Boyd, James A. Russell, Keith R. Walley
    RESPIROLOGY 17(8) 1253-1260 2012年11月  査読有り
    Background and Objective: Interleukin-8 (IL-8) is a central chemokine in acute respiratory distress syndrome (ARDS), and the IL-8 gene contains a functional single nucleotide polymorphism (SNP) -251A/T in its promoter region. We hypothesized that IL-8 -251A/T SNP is associated with PaO2/FiO(2) in critically ill patients. Methods: We conducted genetic-association studies in intensive care units at academic teaching centres using a derivation septic shock cohort (vasopressin and septic shock trial (VASST), n = 467) and a validation post-cardiopulmonary bypass surgery cohort (CPB, n = 739) of Caucasian patients. Patients in both cohorts were genotyped for IL-8 -251A/T. The primary outcome variable in both cohorts was the fraction of patients who had a PaO2/FiO(2) &lt; 200. IL-8 mRNA expression was measured in genotyped lymphoblastoid cells in vitro. Results: The frequency of the patients with PaO2/FiO(2) &lt; 200 was significantly greater in patients who had the AA genotype of -251A/T than in patients who had the AT or TT genotypes in both VASST (AA = 60.8% vs AT and TT = 53.8% and 48.0%, P = 0.038) and the CPB cohort (AA = 37.0% vs AT and TT = 27.0% and 26.0%, P = 0.039). Patients having the AA genotype had a higher probability to remain on mechanical ventilation (P = 0.047) in the first 14 days. Lymphoblastoid cells having the AA genotype had significantly higher IL-8 mRNA expression than cells having the AT or TT genotype (P = 0.022). Conclusions: Critically ill Caucasian patients who had the AA genotype of IL-8 -251A/T had an increased risk of PaO2/FiO(2) &lt; 200. The AA genotype was associated with greater IL-8 mRNA expression than the AT or TT genotypes.
  • 篠崎 広一郎, 織田 成人, 加藤 真優, 渡邉 栄三, 安部 隆三, 中田 孝明, 幸部 吉郎, 大島 拓, 服部 憲幸, 田中 久美子, 平澤 博之
    日本救急医学会雑誌 23(10) 460-460 2012年10月  
  • 服部 憲幸, 織田 成人, 渡邉 栄三, 安部 隆三, 中田 孝明, 幸部 吉郎, 大島 拓, 橋田 知明, 曽根 あゆみ, 柄澤 智史, 川口 留以
    日本救急医学会雑誌 23(10) 468-468 2012年10月  
  • 高橋 和香, 織田 成人, 幡野 雅彦, 渡邉 栄三, 安部 隆三, 中田 孝明, 幸部 吉郎, 大島 拓, 服部 憲幸
    日本外科感染症学会雑誌 9(5) 514-514 2012年10月  
  • 大島 拓, 織田 成人, 渡邉 栄三, 安部 隆三, 中田 孝明, 幸部 吉郎, 服部 憲幸
    日本外科感染症学会雑誌 9(5) 532-532 2012年10月  
  • 小林 美知彦, 大島 拓, 渡邉 栄三, 安部 隆三, 幸部 吉郎, 中田 孝明, 服部 憲幸, 山根 慎滋, 石井 祐行, 古川 豊, 並木 陸, 織田 成人
    日本急性血液浄化学会雑誌 3(Suppl.) 58-58 2012年10月  
  • 大島 拓, 渡邉 栄三, 安部 隆三, 中田 孝明, 幸部 吉郎, 服部 憲幸, 織田 成人
    日本急性血液浄化学会雑誌 3(Suppl.) 68-68 2012年10月  
  • Katherine R. Thain, Taka-aki Nakada, John H. Boyd, James A. Russell, Keith R. Walley
    THROMBOSIS RESEARCH 130(3) 451-457 2012年9月  査読有り
    Introduction: Genetic variation in the Protein C gene (PROC) is associated with altered risk of adverse outcome for a number of diseases. Common single nucleotide polymorphisms (SNPs) in the promoter region and the adjacent 5' region of PROC are associated with Protein C expression. We tested the hypothesis that common SNPs (minor allele frequency &gt;10%) between the frequently studied promoter SNPs -1654 (rs1799808) and -1641 (rs1799809), and the end of PROC intron 2 alter nuclear transcription factor binding. Materials and Methods: We used electrophoretic mobility shift assays with 25-mer oligonucleotides centered on each of the 10 SNPs assessed in this potential regulatory region of the Protein C gene to test for differential binding to nuclear factors isolated from Hep-G2 cells. Results: We found that the G-allele oligo of the intron 2 SNP rs2069915[G/A] bound nuclear factors more avidly than the A-allele (p = 1.9x10(-9), n = 24). Similarly, we found that the C-allele oligo of the intron 2 SNP rs2069916 [C/T] bound nuclear factors more avidly than the T-allele, (p = 3.7x10(-6), n = 19). Cold competition and supershift assays suggested that the protein differentially binding to the C-allele of rs2069916 was USF1. Notably, we observed minimal nuclear factor binding to oligos containing haplotypes of the previously reported -1654 and -1641 SNPs. Luciferase reporter assays that showed the A-T haplotype of rs2069915 and rs2069916 drives transcription significantly more than the C-G haplotype (t-test, P = 0.015, n = 12). Conclusion: Differential transcription factor binding occurs for common SNPs in the 5' intronic regions of PROC which may contribute to PROC regulation and reported PROC SNP - phenotype associations. (C) 2012 Elsevier Ltd. All rights reserved.
  • Petch Wacharasint, Taka-aki Nakada, John H. Boyd, James A. Russell, Keith R. Walley
    SHOCK 38(1) 4-10 2012年7月  査読有り
    We hypothesized that lactate levels even within the normal range are prognostic and that low lactate levels predict a beneficial response to vasopressin infusion in septic shock. We conducted a retrospective analysis using the Vasopressin in Septic Shock Trial (VASST) as a derivation cohort (n = 665), then validated using another single-center septic shock cohort, St Paul's Hospital (SPH) cohort (n = 469). Lactate levels were divided into quartiles. The primary outcome variable was 28-day mortality in both cohorts. We used receiver operating characteristic (ROC) curve analysis to compare the prognostic value of lactate concentrations versus Acute Physiology and Chronic Health Evaluation II scores. We then explored whether lactate concentrations might predict beneficial response to vasopressin compared with noradrenaline in VASST. Normal lactate range is less than 2.3 mmol/L. At enrolment, patients in the second quartile (1.4 &lt; lactate &lt; 2.3 mmol/L) had significantly increased mortality and organ dysfunction compared with patients who had lactate &lt;= 1.4 mmol/L (quartile 1) (P &lt; 0.0001). Quartile 2 outcomes were as severe as quartile 3 (2.3 &lt;= lactate &lt; 4.4 mmol/L) outcomes. Baseline lactate values (area under the ROC curve = 0.63, 0.66; VASST, SPH) were as good as Acute Physiology and Chronic Health Evaluation II scores (area under the ROC curve = 0.66, 0.73; VASST, SPH) as prognostic indicators of 28-day mortality. Lactate concentrations of 1.4 mmol/L or less predicted a beneficial response in those randomized to vasopressin compared with noradrenaline in VASST (P &lt; 0.05). Lactate concentrations within the "normal" range can be a useful prognostic indicator in septic shock. Furthermore, patients whose lactate level is less than or equal to 1.4 mmol/L may benefit from vasopressin infusion.
  • 大島 拓, 織田 成人, 渡邉 栄三, 安部 隆三, 中田 孝明, 幸部 吉郎, 服部 憲幸
    外科と代謝・栄養 46(3) 62-62 2012年6月  
  • Masataka Nakamura, Shigeto Oda, Tomohito Sadahiro, Eizo Watanabe, Ryuzo Abe, Taka-aki Nakada, Yasumasa Morita, Hiroyuki Hirasawa
    Critical Care 16(2) R58 2012年4月11日  査読有り
    Introduction: The aim of the present study was to investigate the relationship between the blood IL-6 level, the blood glucose level, and glucose control in septic patients.Methods: This retrospective observational study in a general ICU of a university hospital included a total of 153 patients with sepsis, severe sepsis, or septic shock who were admitted to the ICU between 2005 and 2010, stayed in the ICU for 7 days or longer, and did not receive steroid therapy prior to or after ICU admission. The severity of stress hyperglycemia, status of glucose control, and correlation between those two factors in these patients were investigated using the blood IL-6 level as an index of hypercytokinemia.Results: A significant positive correlation between blood IL-6 level and blood glucose level on ICU admission was observed in the overall study population (n = 153 r = 0.24, P = 0.01), and was stronger in the nondiabetic subgroup (n = 112 r = 0.42, P &lt 0.01). The rate of successful glucose control (blood glucose level &lt 150 mg/dl maintained for 6 days or longer) decreased with increase in blood IL-6 level on ICU admission (P &lt 0.01). The blood IL-6 level after ICU admission remained significantly higher and the 60-day survival rate was significantly lower in the failed glucose control group than in the successful glucose control group (P &lt 0.01 and P &lt 0.01, respectively).Conclusions: High blood IL-6 level was correlated with hyperglycemia and with difficulties in glucose control in septic patients. These results suggest the possibility that hypercytokinemia might be involved in the development of hyperglycemia in sepsis, and thereby might affect the success of glucose control. © 2012 Nakamura et al. licensee BioMed Central Ltd.
  • Masataka Nakamura, Shigeto Oda, Tomohito Sadahiro, Eizo Watanabe, Ryuzo Abe, Taka-aki Nakada, Yasumasa Morita, Hiroyuki Hirasawa
    CRITICAL CARE 16(2) 2012年  査読有り
    Introduction: The aim of the present study was to investigate the relationship between the blood IL-6 level, the blood glucose level, and glucose control in septic patients. Methods: This retrospective observational study in a general ICU of a university hospital included a total of 153 patients with sepsis, severe sepsis, or septic shock who were admitted to the ICU between 2005 and 2010, stayed in the ICU for 7 days or longer, and did not receive steroid therapy prior to or after ICU admission. The severity of stress hyperglycemia, status of glucose control, and correlation between those two factors in these patients were investigated using the blood IL-6 level as an index of hypercytokinemia. Results: A significant positive correlation between blood IL-6 level and blood glucose level on ICU admission was observed in the overall study population (n = 153; r = 0.24, P = 0.01), and was stronger in the nondiabetic subgroup (n = 112; r = 0.42, P &lt; 0.01). The rate of successful glucose control (blood glucose level &lt; 150 mg/dl maintained for 6 days or longer) decreased with increase in blood IL-6 level on ICU admission (P &lt; 0.01). The blood IL-6 level after ICU admission remained significantly higher and the 60-day survival rate was significantly lower in the failed glucose control group than in the successful glucose control group (P &lt; 0.01 and P &lt; 0.01, respectively). Conclusions: High blood IL-6 level was correlated with hyperglycemia and with difficulties in glucose control in septic patients. These results suggest the possibility that hypercytokinemia might be involved in the development of hyperglycemia in sepsis, and thereby might affect the success of glucose control.

MISC

 161
  • 阿部智一, 大網毅彦, 山川一馬, 中田孝明, 志馬伸朗, 矢田部智昭, 青木善孝, 井上茂亮, 射場敏明, 小倉裕司, 河合佑亮, 川口敦, 川崎達也, 近藤豊, 櫻谷正明, 對東俊介, 土井研人, 橋本英樹, 原嘉孝, 福田龍将, 松嶋麻子, 江木盛時, 久志本成樹
    日本集中治療医学会学術集会(Web) 51st 2024年  
  • 小吉伸幸, 林洋輔, 秦奈々美, 斎藤大輝, 大網毅彦, 服部憲幸, 栃木透, 今西俊介, 安部隆三, 中田孝明
    日本腹部救急医学会雑誌 42(2) 2022年  
  • 島田忠長, 池上さや, 安部隆三, 大島拓, 服部則幸, 大網毅彦, 高橋希, 中田孝明
    日本集中治療医学会学術集会(Web) 49th 2022年  
  • 江木 盛時, 小倉 裕司, 矢田部 智昭, 安宅 一晃, 井上 茂亮, 射場 敏明, 垣花 泰之, 川崎 達也, 久志本 成樹, 黒田 泰弘, 小谷 穣治, 志馬 伸朗, 谷口 巧, 鶴田 良介, 土井 研人, 土井 松幸, 中田 孝明, 中根 正樹, 藤島 清太郎, 細川 直登, 升田 好樹, 松嶋 麻子, 松田 直之, 山川 一馬, 原 嘉孝, 大下 慎一郎, 青木 善孝, 稲田 麻衣, 梅村 穣, 河合 佑亮, 近藤 豊, 斎藤 浩輝, 櫻谷 正明, 對東 俊介, 武田 親宗, 寺山 毅郎, 東平 日出夫, 橋本 英樹, 林田 敬, 一二三 亨, 廣瀬 智也, 福田 龍将, 藤井 智子, 三浦 慎也, 安田 英人, 阿部 智一, 安藤 幸吉, 飯田 有輝, 石原 唯史, 井手 健太郎, 伊藤 健太, 伊藤 雄介, 稲田 雄, 宇都宮 明美, 卯野木 健, 遠藤 功二, 大内 玲, 尾崎 将之, 小野 聡, 桂 守弘, 川口 敦, 川村 雄介, 工藤 大介, 久保 健児, 倉橋 清泰, 櫻本 秀明, 下山 哲, 鈴木 武志, 関根 秀介, 関野 元裕, 高橋 希, 高橋 世, 高橋 弘, 田上 隆, 田島 吾郎, 巽 博臣, 谷 昌憲, 土谷 飛鳥, 堤 悠介, 内藤 貴基, 長江 正晴, 長澤 俊郎, 中村 謙介, 西村 哲郎, 布宮 伸, 則末 泰博, 橋本 悟, 長谷川 大祐, 畠山 淳司, 原 直己, 東別府 直紀, 古島 夏奈, 古薗 弘隆, 松石 雄二朗, 松山 匡, 峰松 佑輔, 宮下 亮一, 宮武 祐士, 森安 恵実, 山田 亨, 山田 博之, 山元 良, 吉田 健史, 吉田 悠平, 吉村 旬平, 四本 竜一, 米倉 寛, 和田 剛志, 渡邉 栄三, 青木 誠, 浅井 英樹, 安部 隆国, 五十嵐 豊, 井口 直也, 石川 雅巳, 石丸 剛, 磯川 修太郎, 板倉 隆太, 今長谷 尚史, 井村 春樹, 入野田 崇, 上原 健司, 生塩 典敬, 梅垣 岳志, 江川 裕子, 榎本 有希, 太田 浩平, 大地 嘉史, 大野 孝則, 大邉 寛幸, 岡 和幸, 岡田 信長, 岡田 遥平, 岡野 弘, 岡本 潤, 奥田 拓史, 小倉 崇以, 小野寺 悠, 小山 雄太, 貝沼 関志, 加古 英介, 柏浦 正広, 加藤 弘美, 金谷 明浩, 金子 唯, 金畑 圭太, 狩野 謙一, 河野 浩幸, 菊谷 知也, 菊地 斉, 城戸 崇裕, 木村 翔, 小網 博之, 小橋 大輔, 齊木 巌, 堺 正仁, 坂本 彩香, 佐藤 哲哉, 志賀 康浩, 下戸 学, 下山 伸哉, 庄古 知久, 菅原 陽, 杉田 篤紀, 鈴木 聡, 鈴木 祐二, 壽原 朋宏, 其田 健司, 高氏 修平, 高島 光平, 高橋 生, 高橋 洋子, 竹下 淳, 田中 裕記, 丹保 亜希仁, 角山 泰一朗, 鉄原 健一, 徳永 健太郎, 富岡 義裕, 冨田 健太朗, 富永 直樹, 豊崎 光信, 豊田 幸樹年, 内藤 宏道, 永田 功, 長門 直, 中村 嘉, 中森 裕毅, 名原 功, 奈良場 啓, 成田 知大, 西岡 典宏, 西村 朋也, 西山 慶, 野村 智久, 芳賀 大樹, 萩原 祥弘, 橋本 克彦, 旗智 武志, 浜崎 俊明, 林 拓也, 林 実, 速水 宏樹, 原口 剛, 平野 洋平, 藤井 遼, 藤田 基, 藤村 直幸, 舩越 拓, 堀口 真仁, 牧 盾, 増永 直久, 松村 洋輔, 真弓 卓也, 南 啓介, 宮崎 裕也, 宮本 和幸, 村田 哲平, 柳井 真知, 矢野 隆郎, 山田 浩平, 山田 直樹, 山本 朋納, 吉廣 尚大, 田中 裕, 西田 修, 日本版敗血症診療ガイドライン2020特別委員会
    日本救急医学会雑誌 32(S1) S1-S411 2021年2月  
    日本集中治療医学会と日本救急医学会は,合同の特別委員会を組織し,2016年に発表した日本版敗血症診療ガイドライン(J-SSCG)2016の改訂を行った。本ガイドライン(J-SSCG2020)の目的は,J-SSCG2016と同様に,敗血症・敗血症性ショックの診療において,医療従事者が患者の予後改善のために適切な判断を下す支援を行うことである。改訂に際し,一般臨床家だけでなく多職種医療者にも理解しやすく,かつ質の高いガイドラインとすることによって,広い普及を目指した。J-SSCG2016ではSSCG2016にない新しい領域[ICU-acquircd weakness(ICU-AW)とpost-intensive care syndrome(POCS),体温管理など]を取り上げたが,J-SSCG2020では新たに注目すべき4領域(Patient-and Family-Centered Care, sepsis treatment system,神経集中治療,ストレス潰瘍)を追加し,計22領域とした。重要な118の臨床課題(clinical question:CQ)をエビデンスの有無にかかわらず抽出した。これらのCQには,本邦で特に注目されているCQも含まれる。多領域にわたる大規模ガイドラインであることから,委員25名を中心に,多職種(看護師,理学療法士,臨床工学技士,薬剤師)および患者経験者も含めたワーキンググループメンバー,両学会の公募によるシステマティックレビューメンバーによる総勢226名の参加・協力を得た。また,中立的な立場で横断的に活躍するアカデミックガイドライン推進班をJ-SSCG2016に引き続き組織した。将来への橋渡しとなることを企図して,多くの若手医師をシステマティックレビューチーム・ワーキンググループに登用し,学会や施設の垣根を越えたネットワーク構築も進めた。作成工程においては,質の担保と作業過程の透明化を図るために様々な工夫を行い,パブリックコメント募集は計2回行った。推奨作成にはGRADE方式を取り入れ,修正Delphi法を用いて全委員の投票により推奨を決定した。結果,118CQに対する回答として,79個のGRADEによる推奨,5個のGPS(good practice statement),18個のエキスパートコンセンサス,27個のBQ(background question)の解説,および敗血症の定義と診断を示した。新たな試みとして,CQごとに診療フローなど時間軸に沿った視覚的情報を取り入れた。J-SSCG2020は,多職種が関わる国内外の敗血症診療の現場において,ベッドサイドで役立つガイドラインとして広く活用されることが期待される。なお,本ガイドラインは,日本集中治療医学会と日本救急医学会の両機関誌のガイドライン増刊号として同時掲載するものである。(著者抄録)
  • 小丸陽平, 小口萌, 貞広智仁, 中田孝明, 服部憲幸, 森口武史, 後藤順子, 志賀英敏, 菊池義彦, 根木茂雄, 重松隆, 川治崇泰, 澤田健, 土井研人
    日本急性血液浄化学会雑誌 12(Supplement) 2021年  

共同研究・競争的資金等の研究課題

 30